Rise in ADMA’s short interest indicates Bearish sentiment

Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Adma Biologics Inc shares valued at $482,144 were purchased by Grossman Jerrold B on Aug 30. At $3.71 per share, Grossman Jerrold B acquired 130,000 shares. The insider’s holdings grew to 443,265 shares worth approximately $2.39 million following the completion of this transaction.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.

Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!

Get the FREE Report with all the details here.


Sponsored

Also, KWON YOUNG purchased 25,000 shares, netting a total of over 97,500 in proceeds. Following the buying of shares at $3.90 each, the insider now holds 277,401 shares.

Before that, Fong Bryant had sold 1,433,304 shares from its account. In a trade valued at $5,544,737, the Director traded Adma Biologics Inc shares for $3.87 each. Upon closing the transaction, the insider’s holdings decreased to 1,433,304 shares, worth approximately $0.0.

Analyzing ADMA Stock Performance

During the last five days, there has been a surge of approximately 4.45%. Over the course of the year, Adma Biologics Inc shares have jumped approximately 19.47%. Shares of the company reached a 52-week high of $5.46 on 02/12/24 and a 52-week low of $4.37 on 01/03/24. A 50-day SMA is recorded $4.71, while a 200-day SMA reached $4.01. Nevertheless, trading volume fell to 2.14 million shares from 2.76 million shares the previous day.

Support And Resistance Levels for Adma Biologics Inc (ADMA)

According to the 24-hour chart, there is a support level at 5.30, which, if violated, would cause prices to drop to 5.19. In the upper region, resistance lies at 5.45. The next price resistance is at 5.50. RSI (Relative Strength Index) is 60.76 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at 0.03, which suggests the price will decrease in the coming days. Percent R is at 15.79%, indicating bullish price movement. Stochastics %K at holding indicates that the stock is to be held.

Is Adma Biologics Inc subject to short interest?

Stocks of Adma Biologics Inc saw a sharp rise in short interest on Jan 31, 2024 jumping by 90000.0 shares to 6.84 million. Data from Yahoo Finance shows that the short interest on Dec 29, 2023 was 6.75 million shares. A jump of 1.32% in short interest reflects a negative sentiment towards the stock. Despite the fact that short shares comprise just 2.35 of the overall float, the days-to-cover ratio (short ratio) jumped to 2.35.

Most Popular